⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 13, 2022The Lancet. Gastroenterology & hepatologyOpen Access

Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review

Catharina J. Alberts Gary M. Clifford Damien Georges Francesco Negro Olufunmilayo Lesi Yvan Hutin Catherine de Martel

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

International Agency for Research on Cancer, World Health Organization.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alberts et al. (2022) studied this question.

synapsesocial.com/papers/69dde45a7ed287395e558432 https://doi.org/10.1016/s2468-1253(22)00050-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Hepatocellular carcinoma attributable to hepatitis B, hepatitis C and other risk factors at global, regional and national levels: an updated systematic review and meta-analysisMeta-Analysis · 2026 · 10 citations
2Viral hepatitis and liver cancerReview · 2017 · 412 citations
3Hepatitis B and C Viruses: Prevalence and co-factors among patients with liver cirrhosis2024
4Global surveillance and control of hepatitis CReview · 1999 · 903 citations
5Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease2024 · 9 citations
6Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub‐Saharan Africa: Systematic review and meta‐analysisMeta-Analysis · 2020 · 42 citations
7Chronic Hepatitis BOriginal Research · 2002 · 443 citations
8Association of Hepatitis B and Hepatitis C Virus Infections With Hepatocellular Carcinoma: A Systematic Review of Virological, Histopathological, and Molecular EvidenceMeta-Analysis · 2026
9ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trialThe Lancet. Gastroenterology & hepatology · 2026
10Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trialThe Lancet. Gastroenterology & hepatology · 2026

More from The Lancet. Gastroenterology & hepatology

More from World Health Organization

More from Centre international de recherche sur le cancer

More from University Hospital of Geneva

More from World Health Organization Regional Office for the Eastern Mediterranean